Overview

To Demonstrate the Relative Bioequivalency of Comparing Single 100 mg Doses Of Cord's 50 mg Desipramine HCL Tablets To Merrell Dow's 50 mg Norpramin Tablets

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

To demonstrate the relative bioequivalency of comparing single 100 mg doses Of Cord's 50 mg Desipramine Hcl tablets to Merrell Dow's 50 mg Norpramin tablets.

Phase:

Phase 1

Details

Lead Sponsor:

Sandoz

Treatments:

Desipramine